At AlchemIQ Labs, we don’t just follow the science we help write it. While others speculate, we lead with rigorous research, innovative formulations, and uncompromising integrity. Our mission is simple but bold: to redefine what’s possible in cellular medicine and performance by delivering compounds that actually work, not just buzzwords. Every formula we create is grounded in peer-reviewed science. Biogoutide is a first-in-class oral therapy designed to go beyond standard GLP-1 drugs. Where current treatments often sacrifice muscle or cause harsh GI side effects, Bioglutide leverages a quadruple receptor agonist strategy, activating IGF-1, GLP-1, GIP, and glucagon receptors simultaneously. This synergy creates a powerful metabolic reset: GLP-1 + GIP → enhance insulin secretion, improve glucose control, and suppress appetite at the brain level. Glucagon receptor → boosts fat oxidation and raises energy expenditure. IGF-1 receptor → protects and preserves lean muscle mass while fat is being mobilized. Unlike injectables, Bioglutide is orally bioavailable, and is being researched as a once-daily, and able to cross the blood–brain barrier for central appetite modulation. Clinical Proof In Phase 2 clinical trials (13 weeks, 125 participants): Up to 13.8% body weight reduction at the top dose (150 mg/day).No muscle loss observed a key differentiator from GLP-1 monotherapies. Mild side effects only (nausea, diarrhea in <8%), with no severe adverse events. These results position Bioglutide as a superior alternative to single-pathway GLP-1 drugs like semaglutide and tirzepatide, especially for those prioritizing fat loss without compromising muscle integrity. Why It Matters Current GLP-1 agonists are effective but blunt tools—they drive appetite suppression and weight loss but often at the expense of lean tissue and overall metabolic resilience. Bioglutide changes the game by: Targeting multiple pathways at once for balanced, durable results. Preserving muscle through IGF-1 activation while accelerating fat oxidation.

I got a few vials of MOTS-c and SS-31, and if I understand correctly, this seems like an interesting complementary combination for improving mitochondrial function. MOTS-c activates AMPK, while SS-31 targets cardiolipin and works as an antioxidant. Here’s what I was thinking: MOTS-c: subcutaneous, 5 mg, 2x per week, for 4 weeks SS-31: subcutaneous, 2 mg daily, 3x per week, mainly on rest days Does this protocol make sense, and what kind of supplements could I add alongside to maximize the benefits of the cycle?

I’ve been running 250mcg SLU-PP-332 fasted AM 5x weekly. Taken with NR, Urolithin A, Fatty15. I’m going to be increasing my dose to 500mcg and curious if people are having more success going with a bolus dose and taking the full 500mcg AM, or splitting it 250 AM and 250 afternoon?

I would love to hear everyone’s thoughts on preferred method of TRT(exogenous injectable route, or oral route). I am currently on testosterone enthanate 300 a week and primobolan enthanate. I have also tried jatenzo (oral testosterone). I have had great results with that where my free test was higher and total was lower. Also are there any natural ways(supplements, nutrition, and sleep). What peptides help with upping testosterone, and balancing estrogen? I would love to hear all of your opinions and learn something new that I may have missed.

I’m hearing reports of people going into anaphylactic shock from MOTS-C administration. I will be utilizing it for the first time in the upcoming week at a planned dose of 5mg 2x weekly. Any insight on these alleged reactions to the injections? Precautions to take? SubQ vs IM administration?